Omeros Corporation (OMER) — Stock Score Summary

Omeros Corporation (OMER) has a MoatMap StockRank of 58/100 based on Quality (31/100), Value (72/100), and Momentum (41/100) factor scores. The current signal is HOLD. Omeros is a clinical-stage biopharmaceutical company with high cash burn and binary regulatory risks. It fails our quality compounder filter, which strictly avoids unprofitable biotech turnarounds.

Omeros Corporation is a biopharmaceutical company developing and commercializing small-molecule and protein therapeutics for inflammation, complement-mediated diseases, and central nervous system disorders, with OMIDRIA as its primary commercial product. It relies on its proprietary G protein-coupled receptor platform and complement inhibitor programs for drug discovery and development. Omeros is a biotechnology company with an emphasis on novel therapeutic targets, aiming to address significant unmet medical needs.

Key Financial Metrics

Price$9.97
Market Cap$807M
P/E (TTM)8.99
P/E (Forward)-341.67
Price/Book-6.06
Return on Invested Capital-49.6%
Gross Margin-190.5%
Operating Margin-176.1%
Free Cash Flow$181M

Omeros Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Omeros Corporation’s (OMER) StockRank?
MoatMap’s StockRank for Omeros Corporation (OMER) is 58/100, with a Hold signal. It is a composite of Quality (31), Value (72), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does Omeros Corporation have an economic moat?
Omeros Corporation (OMER) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Omeros Corporation a buy, hold, or sell?
MoatMap’s current signal for Omeros Corporation (OMER) is Hold, based on a StockRank of 58/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Omeros Corporation in?
Omeros Corporation (OMER) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksOMER deep dive reportAI ChampionsHow we score stocksSense-check another stock